Carbon Dioxide
CAS 124-38-9
Carbon Dioxide (CAS 124-38-9) is a Phase 3 pharmaceutical compound with 0 bioactivity targets and 2 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Air embolism | 35 | 342.976 | 10001526 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| CARBON DIOXIDE | 2034 | SU | MTHSPL |
| Carbon Dioxide | 2034 | SU | MTHSPL |
| carbon dioxide | 2034 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Carbon Dioxide used for in pharmaceutical contexts?
Carbon Dioxide (CAS 124-38-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Carbon Dioxide?
Carbon Dioxide has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Air embolism, Drug ineffective for unapproved indication. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Carbon Dioxide also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Carbon Dioxide with EU status "permitted".
What clinical phase is Carbon Dioxide in?
Carbon Dioxide is rendered with ChEMBL max phase 3.